retatrutide type 2 diabetes trial Results: 28.3% Weight Loss Data Retatrutide Weight Loss Results:Trial Data
Description
Despite the therapeutic success, currently available GLP-1R agonists are suboptimal due to poor patient compliance caused by subcutaneous injections and several side-effects such as nausea and vomiting 4,5
Those studies revealed that GLP-1RA can act directly and indirectly in the arterioles and capillaries and increase microvascular perfusion [34,35,36]
doi: 10.1016/j.steroids.2024.109511 35 PeerF.KuehneltD
Ultimately, we aimed to generate explorative evidence on how their levels might be regulated and their associations with circulating lipids in the setting of human liver regeneration
